Home
|
Inbox
|
Search
|
Event
L1 - UPDATE FROM CDC'S TB TRIALS CONSORTIUM AND TB EPI STUDIES CONSORTIUM
Location: 14A-B
Session Type: Outside Organization Session
Sunday
May
20
12:15 PM
1:15 PM
Description
CDC's two TB research consortia are engaged in clinical trials and epidemiologic studies relevant to the clinical and public health management, and prevention of, tuberculosis. This session provides updates from both groups.
Presentation(s)
- Chair
05-20-2018 12:15 PM - 1:15 PM - Chair
05-20-2018 12:15 PM - 1:15 PM - Latent Class Analysis Assessing Test Characteristics of QFT, TSPOT, TST
05-20-2018 12:15 PM - 12:30 PM - Predictive Value of Latent TB Testing in Children, IGRAs vs. TST
05-20-2018 12:30 PM - 12:45 PM - Pharmacokinetics and Tolerability of High Dose Levofloxacin in MDR-TB
05-20-2018 12:45 PM - 1:00 PM - High Dose Rifamycins for TB: Update on TBTC Study 31/ACTG A5349, and Related Work
05-20-2018 1:00 PM - 1:15 PM
|
Home
|
Inbox
|
Search
|